A case of usual (basaloid)-type vulvar intraepithelial neoplasia that failed to respond to imiquimod cream: clinical implications.
The authors report a case of usual-type (basaloid-type) vulvar intraepithelial neoplasia (VIN) 3 that failed to respond to imiquimod cream. A 51-year-old Japanese woman visited her local gynecologist complaining of vulvar itching. Atypical cells were noted in cytology smears, but nine vulvar biopsy specimens showed benign proliferation of epithelial tissue. The patient was placed under careful observation for 8 months, when the vulvar smears once again showed atypical cells and biopsy specimens revealed VIN3. The patient was then referred to our hospital where she was given a diagnosis of VIN 3, basaloid type of usual type. The biopsy specimens were positive for p16 and the lesions were confirmed to be human papilloma virus (HPV)-related. We recommended simple vulvectomy but the patient requested conservative treatment with imiquimod cream. With her written informed consent, we prescribed imiquimod cream to be self-administered 3 times a week. Colposcopy and pap smear test were performed every 2 weeks. Four weeks after the start of treatment, a fingertip-sized papule was detected at the patient's vaginal introitus. By 6 weeks, the lesion had enlarged, and biopsy specimens revealed invasive squamous cell carcinoma. At 7 weeks, we performed simple vulvectomy. The surgical specimen showed stage pT1b keratinizing-type squamous cell carcinoma. HPV-16 DNA was detected in the specimen.
Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan. shiozaki-takaya@mtf.biglobe.ne.jp
Takaya
T
Shiozaki
Tsutomu
T
Tabata
Kuniaki
K
Toriyabe
Takashi
T
Motohashi
Eiji
E
Kondo
Kouji
K
Tanida
Toshiharu
T
Okugawa
Norimasa
N
Sagawa
D000634:Aminoquinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D000077271:Imiquimod; D008875:Middle Aged; D009367:Neoplasm Staging; D017211:Treatment Failure; D014846:Vulvar Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery
D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod
N Engl J Med. 2008 Apr 3;358(14):1465-73
18385498
J Reprod Med. 2005 Nov;50(11):807-10
16419625
Gynecol Oncol. 1999 Apr;73(1):119-20
10094891
Hum Pathol. 2004 Dec;35(12):1477-83
15619206
Int J Cancer. 2010 Dec 15;127(12):2831-40
21351262
Obstet Gynecol. 2005 Dec;106(6):1319-26
16319258
Curr Opin Obstet Gynecol. 2002 Feb;14(1):39-43
11801875